Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 313

    1.

    Skin autofluorescence: a tool to identify type 2 diabetic patients at risk for developing microvascular complications.

    Gerrits EG, Lutgers HL, Kleefstra N, Graaff R, Groenier KH, Smit AJ, Gans RO, Bilo HJ.

    Diabetes Care. 2008 Mar;31(3):517-21. Epub 2007 Nov 26.PMID: 18039805 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Skin autofluorescence is a strong predictor of cardiac mortality in diabetes.

    Meerwaldt R, Lutgers HL, Links TP, Graaff R, Baynes JW, Gans RO, Smit AJ.

    Diabetes Care. 2007 Jan;30(1):107-12.PMID: 17192342 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Skin autofluorescence as a noninvasive marker of vascular damage in patients with type 2 diabetes.

    Lutgers HL, Graaff R, Links TP, Ubink-Veltmaat LJ, Bilo HJ, Gans RO, Smit AJ.

    Diabetes Care. 2006 Dec;29(12):2654-9.PMID: 17130200 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients.

    Meerwaldt R, Hartog JW, Graaff R, Huisman RJ, Links TP, den Hollander NC, Thorpe SR, Baynes JW, Navis G, Gans RO, Smit AJ.

    J Am Soc Nephrol. 2005 Dec;16(12):3687-93. Epub 2005 Nov 9.PMID: 16280473 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Skin autofluorescence provides additional information to the UK Prospective Diabetes Study (UKPDS) risk score for the estimation of cardiovascular prognosis in type 2 diabetes mellitus.

    Lutgers HL, Gerrits EG, Graaff R, Links TP, Sluiter WJ, Gans RO, Bilo HJ, Smit AJ.

    Diabetologia. 2009 May;52(5):789-97. Epub 2009 Mar 10.PMID: 19274450 [PubMed - indexed for MEDLINE]Related articles

    6.

    Increased accumulation of skin advanced glycation end-products precedes and correlates with clinical manifestation of diabetic neuropathy.

    Meerwaldt R, Links TP, Graaff R, Hoogenberg K, Lefrandt JD, Baynes JW, Gans RO, Smit AJ.

    Diabetologia. 2005 Aug;48(8):1637-44. Epub 2005 Jul 14.PMID: 16021416 [PubMed - indexed for MEDLINE]Related articles

    7.

    Predictors of development and progression of microvascular complications in a cohort of Brazilian type 2 diabetic patients.

    Cardoso CR, Salles GF.

    J Diabetes Complications. 2008 May-Jun;22(3):164-70. Epub 2008 Apr 16.PMID: 18413219 [PubMed - indexed for MEDLINE]Related articles

    8.

    Simple non-invasive assessment of advanced glycation endproduct accumulation.

    Meerwaldt R, Graaff R, Oomen PH, Links TP, Jager JJ, Alderson NL, Thorpe SR, Baynes JW, Gans RO, Smit AJ.

    Diabetologia. 2004 Jul;47(7):1324-30. Epub 2004 Jul 9.PMID: 15243705 [PubMed - indexed for MEDLINE]Related articles

    9.

    Plantar fascia thickness, a measure of tissue glycation, predicts the development of complications in adolescents with type 1 diabetes.

    Craig ME, Duffin AC, Gallego PH, Lam A, Cusumano J, Hing S, Donaghue KC.

    Diabetes Care. 2008 Jun;31(6):1201-6. Epub 2008 Mar 10.PMID: 18332152 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Simple noninvasive measurement of skin autofluorescence.

    Meerwaldt R, Links T, Graaff R, Thorpe SR, Baynes JW, Hartog J, Gans R, Smit A.

    Ann N Y Acad Sci. 2005 Jun;1043:290-8.PMID: 16037251 [PubMed - indexed for MEDLINE]Related articles

    11.

    Skin autofluorescence, a novel marker for glycemic and oxidative stress-derived advanced glycation endproducts: an overview of current clinical studies, evidence, and limitations.

    Mulder DJ, Water TV, Lutgers HL, Graaff R, Gans RO, Zijlstra F, Smit AJ.

    Diabetes Technol Ther. 2006 Oct;8(5):523-35. Review.PMID: 17037967 [PubMed - indexed for MEDLINE]Related articles

    12.

    Cumulative glycemic exposure and microvascular complications in insulin-dependent diabetes mellitus. The glycemic threshold revisited.

    Orchard TJ, Forrest KY, Ellis D, Becker DJ.

    Arch Intern Med. 1997 Sep 8;157(16):1851-6.PMID: 9290544 [PubMed - indexed for MEDLINE]Related articles

    13.

    Risk factors for chronic transplant dysfunction and cardiovascular disease are related to accumulation of advanced glycation end-products in renal transplant recipients.

    Hartog JW, de Vries AP, Bakker SJ, Graaff R, van Son WJ, van der Heide JJ, Gans RO, Wolffenbuttel BH, de Jong PE, Smit AJ.

    Nephrol Dial Transplant. 2006 Aug;21(8):2263-9. Epub 2006 Apr 5.PMID: 16597636 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Predictors of postoperative complications in the patient with diabetes mellitus.

    Tao LS, Mackenzie CR, Charlson ME.

    J Diabetes Complications. 2008 Jan-Feb;22(1):24-8.PMID: 18191074 [PubMed - indexed for MEDLINE]Related articles

    15.

    The advanced glycation end product N(epsilon)-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension.

    Busch M, Franke S, Wolf G, Brandstädt A, Ott U, Gerth J, Hunsicker LG, Stein G; Collaborative Study Group.

    Am J Kidney Dis. 2006 Oct;48(4):571-9.PMID: 16997053 [PubMed - indexed for MEDLINE]Related articles

    16.

    Corneal advanced glycation end products increase in patients with proliferative diabetic retinopathy.

    Sato E, Mori F, Igarashi S, Abiko T, Takeda M, Ishiko S, Yoshida A.

    Diabetes Care. 2001 Mar;24(3):479-82.PMID: 11289471 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    [Is the serum concentration of pentosidine a predictor of cardiovascular events in patients with type 2 diabetes and kidney disease?]

    Busch M, Franke S, Stein G, Wolf G; Collaborative Study Group.

    Dtsch Med Wochenschr. 2007 Sep;132(36):1810-4. German. PMID: 17726651 [PubMed - indexed for MEDLINE]Related articles

    18.

    Advanced glycosylation end products in skin, serum, saliva and urine and its association with complications of patients with type 2 diabetes mellitus.

    Garay-Sevilla ME, Regalado JC, Malacara JM, Nava LE, Wróbel-Zasada K, Castro-Rivas A, Wróbel K.

    J Endocrinol Invest. 2005 Mar;28(3):223-30.PMID: 15952406 [PubMed - indexed for MEDLINE]Related articles

    19.

    Skin autofluorescence in type 2 diabetes: beyond blood glucose.

    Monami M, Lamanna C, Gori F, Bartalucci F, Marchionni N, Mannucci E.

    Diabetes Res Clin Pract. 2008 Jan;79(1):56-60. Epub 2007 Aug 20.PMID: 17707942 [PubMed - indexed for MEDLINE]Related articles

    20.

    Relationship between autofluorescence and advanced glycation end products in diabetic lenses.

    Abiko T, Abiko A, Ishiko S, Takeda M, Horiuchi S, Yoshida A.

    Exp Eye Res. 1999 Mar;68(3):361-6.PMID: 10079144 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data